Anupam Rasayan India Ltd Quality Grade Downgrade: A Detailed Analysis of Business Fundamentals

Overview of Quality Grade Change and Market Context

On 14 August 2026, Anupam Rasayan’s quality grade was downgraded from average to below average, reflecting deteriorating business fundamentals. The company’s Mojo Grade was simultaneously lowered from Sell to Strong Sell, signalling heightened caution for investors. Despite a modest day gain of 0.45% to close at ₹1,212.00 on 17 August 2026, the stock remains under pressure, trading below its 52-week high of ₹1,415.40 and above its 52-week low of ₹1,047.40.

Comparatively, the stock’s year-to-date return of -8.18% slightly outperforms the Sensex’s -8.46%, but the one-month return of -3.99% lags behind the Sensex’s 1.24%. Over longer horizons, Anupam Rasayan has delivered strong returns, with a 5-year gain of 60.53% versus the Sensex’s 40.72%, highlighting past resilience despite recent headwinds.

Profitability Metrics: ROE and ROCE Under Pressure

Return on Equity (ROE) and Return on Capital Employed (ROCE) are critical indicators of a company’s profitability and capital efficiency. Anupam Rasayan’s average ROE stands at a modest 5.89%, while its average ROCE is 9.92%. Both figures are below industry peers such as Bayer CropScience and Sharda Cropchem, which maintain good quality grades supported by stronger returns.

The below-average ROE suggests that the company is generating limited profit relative to shareholders’ equity, which may concern investors seeking efficient capital utilisation. Similarly, the ROCE figure below 10% indicates suboptimal returns on the capital invested in the business, potentially reflecting operational inefficiencies or capital-intensive projects with delayed payoffs.

Growth Trends: Sales and EBIT Growth Remain Healthy but Insufficient

Despite the downgrade, Anupam Rasayan’s five-year sales growth rate remains robust at 22.76%, with EBIT growth at 18.86%. These growth rates demonstrate the company’s ability to expand its top and operating lines consistently. However, the quality downgrade implies that growth alone is not translating into improved profitability or financial health, possibly due to margin pressures or rising costs.

Leverage and Interest Coverage: Signs of Elevated Financial Risk

Financial leverage metrics reveal some cause for concern. The company’s average Debt to EBITDA ratio is 2.72, indicating moderate leverage but edging towards higher risk territory. Meanwhile, the EBIT to Interest coverage ratio of 4.22 suggests that earnings are just over four times the interest expense, a comfortable but not overly strong buffer against rising interest rates or earnings volatility.

Net Debt to Equity at 0.31 reflects a manageable debt level relative to equity, but the presence of 21.79% pledged shares raises governance and liquidity concerns. Institutional holding is relatively low at 8.10%, which may limit the stock’s support from large, stable investors.

Operational Efficiency: Sales to Capital Employed and Taxation

The company’s average Sales to Capital Employed ratio is 0.43, indicating that for every rupee of capital employed, the company generates 43 paise in sales. This ratio is relatively low compared to industry standards, suggesting underutilisation of capital or inefficiencies in asset deployment.

Additionally, the tax ratio of 13.89% is comparatively low, which may reflect tax optimisation strategies or benefits from government incentives. However, the low dividend payout ratio of 8.83% indicates limited cash returns to shareholders, which may dampen investor sentiment, especially among income-focused investors.

Peer Comparison Highlights Relative Weakness

Within the specialty chemicals sector, Anupam Rasayan’s below-average quality grade contrasts with peers such as Bayer CropScience, Sharda Cropchem, and Dhanuka Agritech, all rated as good. Other companies like BASF India, Laxmi Organic, and Rallis India hold average grades, while NACL Industries shares a below-average rating. This peer context underscores Anupam Rasayan’s relative underperformance in key quality parameters.

Stock Performance and Market Capitalisation

As a small-cap stock, Anupam Rasayan’s market capitalisation and liquidity are limited compared to larger peers. The stock’s recent price action shows a slight recovery with a 0.45% gain on the latest trading day, but the overall trend remains subdued. The 1-year return of 3.91% outperforms the Sensex’s -3.21%, yet the year-to-date and one-month returns lag behind broader benchmarks, reflecting mixed investor confidence.

Implications for Investors and Outlook

The downgrade in quality grade to below average and the Strong Sell Mojo Grade reflect a cautious outlook on Anupam Rasayan’s fundamentals. While the company continues to grow sales and EBIT at healthy rates, the limited profitability, moderate leverage, and operational inefficiencies weigh on its investment appeal.

Investors should carefully consider the company’s subpar ROE and ROCE, which indicate challenges in generating adequate returns on equity and capital employed. The moderate debt levels and interest coverage ratio suggest manageable but not negligible financial risk, especially in a rising interest rate environment.

Given the relatively low institutional holding and significant pledged shares, liquidity and governance risks may also be factors to monitor. The company’s dividend policy, with a payout ratio below 10%, offers limited income benefits, which may deter dividend-seeking investors.

Overall, Anupam Rasayan’s fundamentals point to a need for operational improvements and enhanced capital efficiency to regain investor confidence and improve its quality grading.

Conclusion

Anupam Rasayan India Ltd’s recent downgrade in quality grade from average to below average is underpinned by a combination of modest profitability metrics, moderate leverage, and operational inefficiencies despite solid growth rates. The company’s ROE of 5.89% and ROCE of 9.92% lag behind sector leaders, while leverage ratios and pledged shares raise cautionary flags. Investors should weigh these factors carefully against the company’s growth prospects and peer comparisons before making investment decisions.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today